neuromedin U-25



neuromedin U-25

F1FF1R2RR2V3VV3D4DD4E5EE5E6EE6F7FF7Q8QQ8S9SS9P10PP10F11FF11A12AA12S13SS13Q14QQ14S15SS15R16RR16G17GG17Y18YY18F19FF19L20LL20F21FF21R22RR22P23PP23R24RR24N25NN25

SMILES None
InChIKey None
Sequence FRVDEEFQSPFASQSRGYFLFRPRN

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



Bioactivities

neuromedin U-25

F1FF1R2RR2V3VV3D4DD4E5EE5E6EE6F7FF7Q8QQ8S9SS9P10PP10F11FF11A12AA12S13SS13Q14QQ14S15SS15R16RR16G17GG17Y18YY18F19FF19L20LL20F21FF21R22RR22P23PP23R24RR24N25NN25

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.